#thestrat .broadening formations. retracements through previous range. multiple timeframes. #thetruth and nothing but #thetruth.
lots of stops to get taken out on the quarterly chart.
sorry to the haters but the downtrend is broken and the most recent cup and handle break on nasdaq futures puts the initial target back a the previous highs. it will have to retake the previously violated uptrend on it's way to ATH. BIG VOLUME this week will be an important signal
strong growth metrics and good margins. good outlook in current environment. ready to breakout.
incredible margins and revenue growth. EPS growth is excellent. 7 month price consolidation after breaking a downtrend. breaking out of previous resistance and moving above the 10wma on increasing volume. target price $145.
support held past few weeks around $15.70. declining volume on sell-off. owns many patents and has deals to bring many CRISPR style medications through development testing and sales. strong revenue growth in a growing and increasingly accepted medical field. potential breakout target of $29. Biotech stocks are high risk as they depend on experiment success or...
AI and IT company with strong sales growth, high gross margins and improving profit margins. strong uptrend and six month base. A breakout in price and large volume indicates a buying opportunity for trend higher.
nice test and rejection of the 10week moving average. a large volume breakout clearing $52/share would signal a new uptrend.
recent IPO so HIGH RISK but the business idea is one familiar to all investors as being sorely needed in the marketplace. amazing revenue growth and giant TAM potential BUT VERY SMALL MARGIN business. amazing disruptor with strong management. i bought as it was ready to move above 20dma after a quick test and rejection of the 50dma.
normally i dismiss pretty much anyone on youtube but i feel like new class of investors and social media savvy and financial market savvy generation has redistributed and disrupted the way retail investors can access insight and information and ideas about the stock market. i would have never looked at this company but according to the youtube and press releases,...
sometimes, very rarely (this is a high risk and historically LOW REWARD industry), the stars align for a company at a crossroads on it's way to changing the world. it's not a question of if i'm buying the open with this stock, it's how much do i buy and how frequently do i keep buying? no lines needed, if you liked it at $9 you should adore it at $3.
after advancing above the 10 and 20 month moving average on increasing volume, this stock has doubled and broken out on continued strong volume. The chart can be interpreted as a '"W BOTTOM" of a 5 year base. I am long from $.15 and expect the stock to trade at it's previous highs around $.60. ACU is part of a growing industry and has strong revenue growth...
after breaking out and rallying to all time highs I think SKYY will pull back to the 10 week moving average. this would be the 4th time the etf to touch or cross below it's 10 week moving average and would be a sign of an old and tired trend set to reverse. I am long SKYY 95 puts. with an initial target of $90 I am looking for INCREASING volume and expanding daily...
this one has a potential upside target near $17 strong growth predictions and strong EPS forecasts with share buybacks signalling management confidence in their business model
large volume large price increase and initial breakout price target 20-25% higher from current price. I own this stock after holding support at the 10day moving average. the fundamentals of genomic testing and widespread adoption is a significant trend driving change in the healthcare industry.
having basically not moved in weeks the last three days are negative but a lack of volume is unconvincing. the stock needs a catalysts to move prices to new highs and continue trending up. rising volatility at the end of an intermediate length trend is a sign that the fundamentals driving the stock higher are already reflected in the stock price and speculators...
wait for recaputre of recent highs on heavy volume to break out of current range. EPS growth expectations for UBER are strong
Palantir needs a catalyst to break out of this range.